Hypertension in pregnancy for GPs: white coat vs chronic hypertension, aspirin before 16 weeks, pre-eclampsia and the postnatal danger window
A private obstetrician talks GPs through the blood pressure problems they meet first: sorting white coat from chronic hypertension at the booking visit, referring early, starting aspirin before 16 weeks, telling gestational hypertension from pre-eclampsia — and not letting your guard drop after the baby is born.
- Speaker
- Obstetrician and gynaecologist in private practice (presenter not named in the recording). The speaker says they have been working “out of here” for about two years, doing both obstetrics and gynaecology, in what the ASR captures as “the busiest O&G practice”. The very first line reads “So I’m a John” on the ASR — this may be a garbled introduction and is not used as a name here. The speaker offered attendees cards with a direct phone number for clinical questions.
- Audience
- GPs, including shared-care providers; several audience questions (aspirin dosing, bruising on aspirin, ambulatory BP dipping, cervical length, remote-area emergencies) are partly captured.
- Session context
- Otter title Hypertension Management Seminar · id
vMPWJj5zXvuHXgPi1aid6DjkpNg· ~23 min, recorded 21 March 2026 9:27 am AEST. All speakers are labelled only “Unknown Speaker” / Speaker 1–3. No sponsor statement was captured. Summary note: Otter’s auto-summary names the speaker “John” and says emergencies need “rapid IV” treatment — neither is clearly supported by the transcript (see caveats).
Key messages for GPs
- You are usually first. GPs often see women first in pregnancy and are the first to see them postnatally when new symptoms such as headache start — especially women who leave the public system without continuity of care.
- Separate chronic from white coat hypertension at the booking visit: repeat the reading, use the practice nurse, home or pharmacy readings, or a 24-hour ambulatory monitor. Even white coat hypertension carries a higher risk of hypertensive disorders later in pregnancy.
- Chronic hypertension is one of the highest-risk factors in pregnancy — refer early for multidisciplinary care.
- Aspirin 150 mg at night, started before 16 weeks once an intrauterine viable pregnancy is confirmed (the speaker often waits for a normal NIPT at about 10 weeks). If unsure at 15 weeks, start it and say so in the referral — it can always be stopped.
- Pre-eclampsia is multisystem; gestational hypertension is blood pressure alone. Look for proteinuria, abnormal LFTs, falling platelets and fetal growth restriction.
- Don’t drop your guard after birth. The speaker said most eclamptic seizures happen postnatally. Headache, visual “spots”, dizziness, marked oedema plus high blood pressure in the first days after birth needs urgent assessment.
- 160 systolic or 110 diastolic (persistent over a couple of readings) is a hypertensive emergency in pregnancy and postpartum — the patient needs to go to hospital.
At the first pregnancy visit, check blood pressure, work out whether it is truly chronic, look for aspirin risk factors and start aspirin before 16 weeks if indicated. After birth, treat new headache, visual symptoms or swelling with a raised blood pressure as possible postnatal pre-eclampsia until proven otherwise.
Why the GP matters: booking visit and postnatal
The speaker opened by pointing out that whether a woman ends up in public, private or shared care, GPs are often “the first people to see them when they first become pregnant”. In shared care, GPs also see them as the pregnancy goes on.
The group most often missed, in the speaker’s view, is postnatal: women who go through the public system “just have their babies, go home”, and the GP is usually the first to see them “when something changes, like if they get new symptoms, like headaches”. That is an important presentation (see postnatal pre-eclampsia).
Chronic or white coat hypertension?
The first category is hypertension that a woman brings into the pregnancy — defined as any hypertension before 20 weeks (the ASR says “before 20 years”; the context and standard definitions make 20 weeks clear). Many of these women are healthy and have rarely seen a doctor, so the booking visit may be their first blood pressure check in years.
One of the most important distinctions not to miss, the speaker said, is chronic hypertension versus white coat hypertension, “because there’s a fair bit of white coat hypertension around.” If the woman has lots of comorbidities, chronic hypertension may be obvious. Otherwise, the speaker’s practical (and, in their words, “not really evidence based”) steps are:
- Repeat the blood pressure a couple of times during the consultation to see if it settles.
- Ask the practice nurse to take it.
- Book a follow-up and in the meantime ask her to buy a home blood pressure machine (“not cheap, but it’s not that expensive these days”) or have it checked at a pharmacy a couple of times. Normal readings everywhere except with you are “a pretty good sign” of white coat hypertension.
- More formally, organise 24-hour ambulatory blood pressure monitoring — “often a bit of a pain to organise”, but it can distinguish the two at any point in pregnancy.
Even true white coat hypertension carries a higher chance of developing other hypertensive disorders later in the pregnancy. Keep watching her blood pressure through the pregnancy.
Chronic hypertension: refer early
“Chronic hypertension is one of the highest risk factors in terms of pregnancy,” so refer early to whichever service she will use — public, private or a midwifery/shared-care model (the ASR’s “LGB” is unclear). These women need multidisciplinary care.
- Private care: if possible, refer to a renal physician at the same hospital where she will deliver, so both specialists are on site at the birth. The speaker called this “the best combination”.
- Public care: the public hospital typically takes over, “which is fine”.
Aspirin to prevent preterm pre-eclampsia
Aspirin has been shown in studies to potentially prevent preterm pre-eclampsia. The theory given: pre-eclampsia stems from problems when the placenta first implants, and aspirin’s antiplatelet (“blood thinner”) effect is thought to help implantation and blood flow.
| Question | What the speaker said |
|---|---|
| When to start | Before 16 weeks — “that’s the best time to start it.” |
| How early | Not before a confirmed intrauterine viable pregnancy — if it were ectopic and needed surgery there is a theoretical bleeding risk. The speaker typically waits for a normal NIPT, so usually about 10 weeks. |
| Dose | 150 mg at night — “the recommended dose”. Studies range from 75 to 300 mg, but most look at about 150 mg. |
| Practical tablet | The easiest approach: break a 300 mg tablet in half and take half each night. Some prefer to stay on 100 mg because it is coated — “a lot of the research has been based on a wide range.” |
| The other half | Some advise discarding it; the speaker often lets a first-time mother keep it for the next night, but warns women with children at home to store it safely. “Judge it by the patient.” |
| Benefit size | The number needed to treat is relatively high — about 30 to 50 high-risk women to prevent one case (as stated). Still worth doing because it is a low-risk intervention. |
The speaker added a reassuring note for women who arrive late (for example transferring in at 20 weeks) and are upset they were never offered aspirin: with good monitoring, the reality is that either it probably would not have worked for them, or they were not going to develop hypertension anyway.
Who should get aspirin?
| Strong indications (as listed) | “Softer” factors that may tip the balance |
|---|---|
| Previous pre-eclampsia | IVF pregnancy (especially with another borderline factor) |
| Chronic hypertension | Twins |
| Renal disease | Older maternal age — the threshold used to be 35, then 40, and is “trending upwards”; it is a combination |
| Diabetes, especially type 1 | Raised BMI |
The speaker said clinicians are “getting a bit more lax” about the softer markers because the intervention is so low-risk — there is “only a theoretical risk of bleeding”, without evidence of actual increased bleeding (as stated). Examples given: a 38-year-old with an IVF pregnancy and a raised BMI — aspirin “probably warranted”; twins at age 42 — “pretty easy” to decide.
Public antenatal services may not see a woman until about 20 weeks or later. “It’s very easy to start before 16 weeks. So if you’re seeing someone at 15 weeks and you’re not sure whether to start it, start it until they get seen, and just in the referral say ‘I’ve started it because of these risk factors’. If [the specialist] feels it’s not necessary, just stop.” The speaker acknowledged this may not be everyone’s opinion.
First-trimester pre-eclampsia screening
Asked about pre-eclampsia screening at 13 weeks, the speaker explained it is done alongside combined first-trimester screening and uses:
- Blood tests
- Blood pressure at the visit
- Uterine artery Dopplers, looking for high resistance — the idea being that the body is working hard to get blood to the uterus, so the placenta may not implant as well
These go into an algorithm that gives a risk. More than 1 in 100 is called high risk, and aspirin is started even without other risk factors. Borderline results (the example: 1 in 110, slightly overweight, a little older) become a shared decision — “you’re low risk by the numbers … but the risk [of aspirin] is so low”, so the speaker always gives the woman the option.
When to stop aspirin
- Usually stop at 36 weeks. The studies look at the risk of preterm pre-eclampsia (before 37 weeks), so there is no shown benefit in continuing, and aspirin has a washout period with a theoretical bleeding risk around birth.
- If early birth is expected (for example twins), stop earlier — the speaker usually stops at about 34 weeks for twins.
Antihypertensives in pregnancy
Choice depends on the patient’s risk factors. As the speaker described it:
| Medicine | Points made |
|---|---|
| Labetalol (ASR “libidolo”) | Usual first choice; “pretty safe”. The main caution is asthma. Can start as low as 100 mg twice daily depending on the blood pressure, though the speaker called that a fairly “homeopathic” dose — many women end up needing more (the ASR is unclear whether this means a higher dose or a second agent). |
| Methyldopa | “Good during pregnancy”, but the speaker described a relatively strong association with postnatal depression. If a woman was started on methyldopa (for example by the hospital or her renal physician), switch to something else after birth. |
| Other agents | The speaker noted more options can be used postnatally than in pregnancy (this part of the ASR is garbled; drug names were not captured). |
Gestational hypertension vs pre-eclampsia
After 20 weeks, the question becomes whether new hypertension is gestational hypertension or pre-eclampsia:
- Gestational hypertension: blood pressure above 140 systolic or 90 diastolic, with everything else “absolutely perfect”.
- Pre-eclampsia: a multisystem disorder — hypertension plus involvement of any other system. The best-known is proteinuria (the speaker quoted “anything more than 30”; the units were not stated — in Australia the urine protein:creatinine ratio is usually reported in mg/mmol). Others include deranged LFTs, changing platelets and fetal growth restriction — “the uterus is an organ system”, so a hypertensive woman with a small baby can meet the definition even if her bloods and urine are perfect.
Monitoring and timing
- Women with gestational hypertension are more likely to progress to pre-eclampsia, so timing of birth matters and regular review is needed to check no other system becomes involved.
- Who reviews depends on the model of care. A privately referred woman would be managed by the obstetrician, keeping the GP in the loop; in public shared care it depends on the reviews arranged.
- Ideally at least fortnightly. Gestational hypertension is usually diagnosed after 30 weeks, so roughly fortnightly visits until 36 weeks and then weekly. Things can change quickly, especially when hypertension starts earlier.
- Once pre-eclampsia is diagnosed, the speaker said birth is likely within about two to three weeks, because the only cure is delivery (of the placenta, and with it the baby).
Postnatal pre-eclampsia: the danger window
The speaker called postnatal hypertension “a really important one” for GPs. A woman who had a normal pregnancy can present, especially in the first couple of days after birth, with:
- headaches
- dizziness
- visual “spots”
- significant oedema
- and raised blood pressure
Diagnosis is harder after birth: she is probably still bleeding, so a urine sample will likely be contaminated (unless catheterised — not something done in general practice). So rely on bloods and symptoms:
- Hypertensive with abnormal bloods → pre-eclampsia.
- Hypertensive with normal bloods but significant symptoms → still treat seriously.
“Everyone’s happy … you’re good to go. But that’s when you’re most likely to have progression to eclampsia.” The speaker said most eclamptic seizures actually happen postnatally rather than in pregnancy — probably because pregnancy is managed so well that vigilance drops afterwards.
Examination tips
- Check blood pressure, reflexes and clonus.
- You don’t need a tendon hammer — the speaker hasn’t used one “in 10 years”. If a woman is truly pre-eclamptic and hyper-reflexic, a tap with your hand on the knee will show it; obvious three to four beats of clonus is “diagnostic, basically”.
Severe hypertension: thresholds and first steps
Systolic over 160 or diastolic over 110 is a hypertensive emergency in pregnancy (and postnatally). If it persists over a couple of readings, she needs to go to hospital — above this level the risk of stroke and seizure rises steeply.
A GP from a remote area asked whether they should give medicine before transfer. The speaker said yes, it is a good idea, and described (as far as the ASR allows):
- The preferred option is a rapid-acting oral antihypertensive — the ASR reads “the theta been rapidly”, most likely immediate-release nifedipine (the drug name is our best reading, not confirmed) — given as 10 or 20 mg, rechecking blood pressure in 10 to 15 minutes. It can be repeated (two or three doses) until the pressure comes down.
- If an IV cannula is available, the speaker mentioned running a bag of fluids slowly while giving the antihypertensive (ASR garbled — “a bag of claws”).
- Hydralazine is a good alternative where available.
- Labetalol will also work but is slower; the rapid-acting option was described as the best.
Q&A highlights
Bruising on aspirin — stop it?
“Probably not.” If it is purely bruising, with no other clinical concern — pregnancy itself brings bleeding gums and more nosebleeds because of the extra circulating blood — the speaker would continue, unless there is a clinical concern about the pregnancy or actual bleeding somewhere else (the ASR mentions “abdominal”).
No night-time dipping on ambulatory monitoring?
Not significant for the diagnosis itself. Most people have a small drop at night; it becomes important mainly when starting antihypertensives, because a woman whose pressure is high in the day but relatively low overnight could drop too far on treatment.
Cervical length and pre-eclampsia?
“Not particularly” — there is not much link between the two. Cervical length matters for other reasons (the speaker mentioned “more than two and a half centimetres”, depending on risk factors).
GP clinic checklist
- Take blood pressure at the first pregnancy visit. If raised, repeat it, use the nurse, home or pharmacy readings, or ambulatory monitoring to separate chronic from white coat hypertension.
- Chronic hypertension (before 20 weeks) → refer early; for private care, a renal physician at the delivering hospital is ideal.
- Screen for aspirin risk factors: previous pre-eclampsia, chronic hypertension, renal disease, diabetes (especially type 1); softer factors such as IVF, twins, older age and raised BMI.
- Confirm a viable intrauterine pregnancy (the speaker often waits for a normal NIPT, ~10 weeks), then start aspirin 150 mg at night before 16 weeks if indicated. If unsure, start and document it in the referral.
- Note the 13-week pre-eclampsia screen result: >1 in 100 = high risk.
- Stop aspirin at about 36 weeks (about 34 weeks for twins), or as the obstetric team advises.
- After 20 weeks, new BP ≥140/90 → check urine protein, LFTs, platelets and fetal growth; liaise with the obstetric team.
- If a woman is on methyldopa, plan a switch after birth given the reported link with postnatal depression.
- Postnatally, treat headache, visual spots, dizziness or marked oedema with raised blood pressure as possible pre-eclampsia: check BP, reflexes, clonus and bloods.
- BP ≥160 systolic or ≥110 diastolic on repeat = emergency. Treat per local protocol and transfer urgently.
Transcript caveats
Presenter: not named in the recording. The ASR opening “So I’m a John” may be a garbled introduction; Otter’s summary turns it into “John has been working in the practice”, which is not used here.
Emergency drug: the ASR “the theta been rapidly … 10 or 20 milligrams” is read as immediate-release nifedipine, but this is an inference. Otter’s summary says “rapid IV administration”; the transcript does not clearly mention IV treatment, except possibly running fluids if a cannula is in.
Labetalol dosing: “start as low as 100 mg BD” is clear; what follows (“usually end up on two anti GBs”) is not.
Proteinuria: the threshold “more than 30” was given without units.
Drug names: labetalol (“libidolo”, “libital oil”, “libido, lol”), methyldopa (“methyl dopa”), NIPT (“nipt”) and eclampsia (“epilepsy”) are our best readings of the ASR.
Audience questions are partly captured; answers are summarised from the speaker’s side.
Opinion vs evidence: the speaker clearly labelled some advice (the white coat steps, starting aspirin when unsure) as personal practice rather than evidence.